Director, US HCP Marketing, Rheumatology, Autoimmune Myositis

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi‑dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first‑in‑class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.

We are building a new kind of biotech company, one that maintains its roots as a science‑based start‑up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. argenx is a global immunology company developing therapies for individuals living with autoimmune diseases.

argenx is building a world‑class portfolio of biologics in both early and late stages of development. VYVGART® / VYVGART Hytrulo® (efgartigimod) is approved for generalized Myasthenia Gravis (gMG) and Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and is being evaluated for several additional indications, including three rheumatology indications: autoimmune myositis, Sjögren’s disease and systemic sclerosis.

The Director, US HCP Marketing will develop strategies and execute HCP‑focused initiatives for argenx’s upcoming autoimmune myositis launch. The role will help create an integrated customer experience across field, digital, media, and peer‑to‑peer channels and will support:
Development of unbranded strategy and tactics, including messaging, materials, media, and execution to support market development;
Development of brand launch strategy and tactics, including the brand campaign, messaging, materials, media, and execution to support promotion of VYVGART Hytrulo;
Development and execution of peer‑to‑peer education, advisory boards, speaker bureau content, and training materials;
Development of integrated omnichannel plans that coordinate personal and non‑personal engagement across the customer journey. This role will report to the Senior Director of US HCP Marketing, Rheumatology Lead, and will partner closely with internal cross‑functional partners and external agencies to plan and implement integrated personal and non‑personal engagement for autoimmune myositis. In close collaboration with the broader HCP Community, this role will support VYVGART Hytrulo® brand strategy and pull‑through across the Commercial Field Team, KOL engagement, and media and digital channels.

The Director will also deliver on key brand expectations, including Brand Planning, Launch Readiness, and Quarterly Business Reviews. This is an exciting time to join an innovative company. We seek a marketer who thrives in a nimble, fast‑paced environment, is passionate about science, and is deeply motivated by delivering value to people living with rare diseases.

• Support the strategy and execution of the autoimmune myositis disease state education campaign, including messaging, creative development, channel planning, and measurement
• Support US launch readiness through the development and execution of the HCP branded VYVGART Hytrulo strategy, messaging, content strategy, promotional assets, and tactical plan
• Shape and support the execution of integrated HCP media and omnichannel plans across unbranded and branded channels
• Plan and execute commercial advisory boards, including advisor selection, workshop design, stimuli development, and synthesis of insights to inform cross‑functional decision‑making
• Support the strategy and execution of peer‑to‑peer education programs, including speaker bureau content, speaker training, program execution, and…